Carnegie Investment Counsel grew its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 11.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange ...
DexCom is a leader in the continuous glucose monitoring (CGM) market, or devices that help diabetes patients track their blood glucose levels. The company encountered some issues in 2024, including ...